Patents
Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175)
09/2008
09/25/2008WO2007068394A8 Diphenyl urea derivatives
09/25/2008US20080234384 Biaryl and biheteroaryl compounds useful in treating iron disorders
09/24/2008CN100420670C Method for synthesizing dextrorotation S-(2-amido propyl)-methyl isothiurothiuronium salts
09/18/2008US20080227995 Process of Sulfonating 4-Aminobenzonitriles
09/02/2008CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
08/2008
08/28/2008US20080207764 Novel Benzamidine Derivatives Having Anti-Inflammatory and Immunosuppressive Activity
08/28/2008US20080207760 Pharmaceutical Compositions For and Methods of Inhibiting Hcv
08/20/2008EP1957447A1 Indanyl-and tetrahydronaphtyl-amino-thiourea compounds for combating animal pests
08/20/2008EP1285909B1 Process for the production of nitrogen compounds
08/19/2008US7414076 Methods and compositions for treating amyloid-related diseases
08/12/2008CA2310985C Process for manufacture of n-alkoxy (or aryloxy)carbonyl isothiocyanate derivatives in the presence of n,n-dialkylarylamine catalyst and aqueous solvent
08/12/2008CA2310984C Process for manufacturing n-alkoxy (or aryloxy)carbonyl isothiocyanate derivatives using n,n-dialkylarylamine as catalyst
08/07/2008WO2008092410A1 Preparation method of thioureas or salts thereof
08/07/2008US20080188489 Cell differentiation inducer
08/06/2008EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
08/06/2008EP1311475B1 Aminocyclohexane derivatives
07/2008
07/24/2008US20080176821 phosphoryl-di(glutamate dibenzylester or dihydroxyamide) derivatives; neuroleptic agent, neurodegenerative diseases, neuropathic pain, epilepsy, ischaemia, schizophrenia, amyotrophic lateral sclerosis, Alzheimer's, Parkinson, Huntington diseases;
07/23/2008CN101225065A Chiral compound having multi-hydrogen bonds dual-function as well as synthetic method and use thereof
07/16/2008EP1392655B1 Potassium channel openers
07/16/2008CN100402492C Androgen receptor suppressors in treatment of hirsutism, acne and androgenetic alopecia
07/02/2008EP1939625A2 Methods for ligand discovery
07/02/2008EP1939173A1 O-substituted-dibenzyl urea- or thiourea- derivatives as trpv1 receptor antagonists
07/02/2008EP1730117A4 Thiourea compositions and uses thereof
06/2008
06/26/2008WO2008074756A1 Novel biphenyl thio-urea derivatives useful as potassium channel modulators
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/18/2008EP1931622A1 Pesticide phenyloxy substituted phenylamidine derivatives
06/11/2008CN101195597A 1-substituted-4,4-2 substituted thiosemicarbazide compounds, production method and uses of the same
06/10/2008US7385063 Method for preparing imidazole derivatives
06/05/2008DE102006056311A1 Use of guanidine derivatives as accelerators for hardening epoxy resin systems
06/04/2008EP1927604A1 Functional monomers for molecular recognition and catalysis
06/03/2008US7381745 Central nervous system disorders; psychological disorders
05/2008
05/29/2008US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
05/28/2008EP1577294A4 S-substituted n-1- (hetero)aryl alkyl-n - (hetero)aryl alkylysothiocarbamides, method for the production thereof, physiologically active s-substituted n-1- (hetero )aryl alkyl-n - (hetero)aryl alkylysothiocarbamides,a pharmaceutical compound and curing method
05/27/2008US7378525 CCR8 inhibitors
05/22/2008WO2008059299A1 CHIRAL CYCLIC ß-AMINO ACIDS AND THEIR DERIVATES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THE USE OF SUCH COMPOUNDS
05/22/2008US20080118870 Sulfur Atom-Containing Anti-Reflective Coating Forming Composition For Lithography
05/21/2008CN100389105C Substituted benzal cyclopentanone derivatives and their use
05/20/2008CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them
05/20/2008CA2169694C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/15/2008US20080113975 Thiourea compounds
05/14/2008CN101179936A 1-(1,2-diphenyl-ethyl)-3-(2-hydroxyethyl)-thiourea compounds for combating animal pests
05/13/2008US7371755 Antiviral agents
04/2008
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/24/2008US20080097102 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
04/24/2008US20080096875 Hepatitis C virus infection; thiourea-substituted dibenzofuran, fluorene, or carbazole compounds
04/23/2008EP1303483B1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/17/2008WO2008043840A2 Anti-infective thiourea compounds
04/16/2008EP1910280A2 Process of sulfonating 4-aminobenzonitriles
04/16/2008EP1909783A2 Illudin analogs useful as anticancer agents
04/15/2008US7358359 Antibacterial agents
04/10/2008US20080085936 Antiinflammatory agents, analgesics; 2-halo-4-hydroxy-5-methoxyphenyl-functional urea or thiourea compounds such as 1-(p-trifluoromethylbenzyl)-3-(2-iodo-4-hydroxy-5-methoxybenzyl)thiourea
03/2008
03/20/2008US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
03/19/2008EP1805138B1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor
03/13/2008US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea
03/11/2008CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity
02/2008
02/27/2008EP1891028A1 Non-peptidic inhibitors of akap/pka interaction
02/27/2008EP1890541A2 1-(1,2-diphenyl-ethyl)-3-(2-hydroxyethyl)-thiourea compounds for combating animal pests
02/26/2008US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide
02/21/2008CA2660911A1 Thiourea compounds
02/19/2008US7332553 Functional monomers for molecular recognition and catalysis
01/2008
01/29/2008US7323602 Reacting chemical intermediate with a base
01/29/2008US7323496 Compounds for treatment of inflammation, diabetes and related disorders
01/24/2008WO2008009881A1 Chemical compounds
01/23/2008CN101108820A Isothiuronium salt and method of manufacturing the same and method for manufacturing substituted benzene ethyl mercaptan compounds
01/22/2008CA2374362C Urea derivatives as hiv aspartyl protease inhibitors
01/17/2008US20080015180 Methods and compositions for treating amyloid-related diseases
01/15/2008US7319104 hPPARs activators
01/10/2008WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
01/10/2008WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
01/10/2008DE102006028451A1 Verfahren zur Herstellung von N-Acyl-α-Aminonitrilen A process for preparing N-acyl-α-aminonitriles
01/08/2008US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents
12/2007
12/13/2007WO2007142426A1 Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same
12/13/2007WO2007141423A1 Ppar enhancing derivatives, method for preparing same and therapeutic use thereof
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/05/2007EP1862454A1 Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same
11/2007
11/29/2007WO2007137107A2 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
11/29/2007WO2007134971A1 Benzoyl-substituted alanines
11/28/2007CN100351229C 5,11,17,23-tetra (p-tert-butyl)-25,27-dilp-nitrobenzenethioureido-(1'R,2'R)-1',2'-diphenylethylamino-carbonyl methoxyl J-26, 28-dihydroxyl cup [4} arene
11/13/2007CA2157859C Amino acid-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
11/08/2007WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007US20070260058 N-phenyl-1,3-thiazol-2-amine derivatives, useful in the treatment of neurodegenerative disorders, such as Alzheimer's disease
11/08/2007US20070259961 Novel acyl urea, thiourea, carbamate, thiocarbamate and related compounds are provided which are effective in inhibiting the cytokine-mediated inflammatory response in cultured cells, in ameliorating bone destruction in an animal model of arthritis and in lowering blood glucose levels in animal or cancer
11/07/2007CN100347151C Novel aminobenzoephenones
10/2007
10/31/2007CN101062023A Selective androgen receptor modulators and methods of use thereof
10/25/2007US20070249720 Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability
10/24/2007EP1287006B1 Antitumoral compounds
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/17/2007EP1844002A1 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/04/2007DE102006014335A1 Verdichtung von Sauerstoff Compression of oxygen
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/27/2007CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
09/25/2007CA2415551C Aniline derivatives
09/19/2007EP1198456B1 Potassium channel openers
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/11/2007CA2255858C Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
09/06/2007US20070208177 Acid addition salt of 1-(isothiuroniummethyl)cyclopropaneacetonitrile; intermediate for preparing the side-chain precursor 1-(mercaptomethyl)cyclopropaneacetic acid, which is useful in the synthesis of montelukast and salts thereof
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
08/2007
08/30/2007WO2007096124A1 Process for the preparation of adamantanamines
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 32